Safety and Efficacy Study of IVB103 Injection in Subjects With Neovascular (Wet) Agerelated Macular Degeneration (nAMD).
Clinical trial NCT06737354 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06737354
- Sponsor
- InnoVec Biotherapeutics Inc.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-22
- Primary completion
- 2027-12-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.